532039 — Zenotech Laboratories Cashflow Statement
0.000.00%
- IN₹3.50bn
- IN₹3.26bn
- IN₹408.33m
Annual cashflow statement for Zenotech Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 108 | -12.2 | 99 | 145 | 111 |
Depreciation | |||||
Non-Cash Items | -65.3 | 12 | 10.4 | -3.15 | -9.18 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 22.8 | -7.02 | -2.49 | -6.96 | -54.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 114 | 57.4 | 177 | 207 | 118 |
Capital Expenditures | -217 | -49.1 | -19.4 | -62.3 | -42.3 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 9.54 | 0.937 | 0.986 | 4.07 | -169 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -208 | -48.2 | -18.4 | -58.2 | -212 |
Financing Cash Flow Items | -11.2 | -15.5 | -12.2 | -1.12 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -27 | 4.53 | -159 | -61.1 | 0 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -121 | 13.8 | -0.429 | 87.3 | -93.3 |